| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000017961 |
| Receipt No. | R000020738 |
| Scientific Title | Non-invasive Neuromodulation for Ventricular Electrical Etorm: RESCUE VT |
| Date of disclosure of the study information | 2015/06/18 |
| Last modified on | 2019/06/22 (Ver. 3) |
| Basic information | ||
| Public title | Non-invasive Neuromodulation for Ventricular Electrical Etorm: RESCUE VT | |
| Acronym | RESCUE VT | |
| Scientific Title | Non-invasive Neuromodulation for Ventricular Electrical Etorm: RESCUE VT | |
| Scientific Title:Acronym | RESCUE VT | |
| Region |
|
|
| Condition | |||
| Condition | Ventricular tachycardia/ventricular fibrillation | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | In healthy subject:
To evaluate the effect of stellate ganglion phototherapy on autonomic nervous system. In patients with ventricular arrhythmia: To clarify that stellate ganglion phototherapy suppresses ventricular arrhythmia in patients with ventricular arrhythmias. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Healthy population; Heart rate, QT, QTc in 12 lead ECG
Total heart beats, maximum/minimum/average heart rate, maximum RR interval, LF, HF, LF/HF in ambulatory ECG catecholamine concentration, WBC count Patients; in addition to the parameters as healthy population, number of ventricular arrhythmia episodes |
| Key secondary outcomes | Patients: survival rate of 2 years, number of ventricular arrhythmia episodes, recurrence of ventricular arrhythmia |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Linear Polarized Near lnfrared Ray lrradiation or Xenon Phototherapy | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Healthy population:
One with normal 12 lead ECG and without any previous medical history. Patients: 1) Without ICD; patients with drug refractory VA and in a condition of electrical storm. Patients with VA and he/she could not undergo catheter ablation due to poor general status, or patients with VA in whom CA was not effective. 2) With ICD; patients with frequent ICD therapies for VA and he/she could not undergo CA or CA was not effective. |
|||
| Key exclusion criteria | When the patient or his/her family does not agree with the enrollment | |||
| Target sample size | 70 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kyorin University, School of Medicine | ||||||
| Division name | Second Department of Internal Medicine | ||||||
| Zip code | |||||||
| Address | Shinkawa 6-20-2 Mitaka-shi, Tokyo, JAPAN | ||||||
| TEL | 0422-47-5511 | ||||||
| norikom627@gmail.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kyorin University Hospital | ||||||
| Division name | Cardiology | ||||||
| Zip code | |||||||
| Address | Shinkawa 6-20-2 Mitaka-shi, Tokyo, JAPAN | ||||||
| TEL | 0422-47-5511 | ||||||
| Homepage URL | |||||||
| norikom627@gmail.com | |||||||
| Sponsor | |
| Institute | Kyorin University, School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | University of Tsukuba Hospital, Yokohama Rosai Hospital, Sanin Rosai Hospital, Kanazawa Medical Center, Toyota Kosei Hospital |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 杏林大学医学部 (東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000020738 |